EUSA Pharma Completes Acquisition Of Cytogen Corporation DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has...
EUSA Pharma Completes Acquisition Of Cytogen Corporation DOYLESTOWN, PA and OXFORD, England, May 9 /CNW/ - EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has completed its...
EUSA Pharma Completes Acquisition Of Cytogen Corporation DOYLESTOWN, PA and OXFORD, England, May 9 /CNW/ - EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has completed its...
Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Develo /PRNewswire/ - Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, and Thermo Fisher Scientific have entered into an agreement under which Dalton will use a proprietary Thermo Fisher manufacturing...
Astellas Mycamine Licensed for Use in Europe The European Medicines Agency (EMEA) has announced the marketing authorisation of Mycamine, Astellas Pharma Europes treatment for invasive candidiasis, oesophageal candidiasis and prophylaxis of Candida infection in patients undergoing...
Par Pharmaceutical Reports First Quarter 2008 Results Reports First Quarter Adjusted EPS of $0.17 per Diluted Share Provides Full-year 2008 EPS Guidance and Projects its Pipeline Opportunities WOODCLIFF LAKE, N.J., May 8 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.(NYSE...
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular De LEVERKUSEN, Germany, MONTVILLE, New Jersey and TARRYTOWN, New York, May 08, 2008 /PRNewswire-FirstCall/ -- Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc.today announced that the first patient has been dosed in the VIEW 2...
EUSA Pharma Completes Acquisition Of Cytogen Corporation DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has...
Advent International Acquires LaborMed Pharma Advent International, a leading global buyout firm, has completed the acquisition of LaborMed Pharma from its founders.LaborMed, based in Bucharest, manufactures and distributes generic pharmaceuticals, primarily for...
Ipsen: Adenuric (Febuxostat) Receives Marketing Authorisation in the European Union - Regulatory News: Ipsen (Paris:IPN) today announced that the European Commission granted marketing authorisation for Adenuric(R) (febuxostat) for the treatment of chronic hyperuricaemia in gout.Adenuric(R) thus pioneers the first major...
Sciele Pharma to Present at Bank of America Health Care Conference The audio presentation is being broadcast on the Internet and may be accessed at the Company's website, www.sciele.com.Sciele Pharma, Inc.
Background Sciele Pharma, Inc.
is a pharmaceutical company specializing in...
Get ready for a biotech buyout boom Next week, I'm giving a speech at the 13th Annual Pharmaceutical and Biotech Licensing and Deal Making Summit.To prepare for my presentation, I spoke to many of my hedge fund contacts.
Given that I'm already a biotech bull, I...
Takeda sees big profit slump on Millennium costs Stocks mentioned in this article Amgen Inc (AMGN) Stock Quote, Chart, News, Add to Watchlist Millennium Pharmaceuticals Inc (MLNM) Stock Quote, Chart, News, Add to Watchlist TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd...
EUSA Pharma Completes Acquisition Of Cytogen Corporation , 1:07 AM EST Under the terms of the acquisition agreement, Cytogen shareholders will receive $0.62 Cytogen brings to EUSA three oncology and pain control products, a US specialty sales force and an established commercial infrastructure.
IDM Pharma Reports First Quarter Financial Results IRVINE, Calif., May 8 /PRNewswire-FirstCall/ -- IDM Pharma, Inc.(Nasdaq: IDMI - News) today reported financial results for the quarter ended March 31, 2008.
Financial information presented represents the consolidated results of...
Dalton Pharma Services Licenses Thermo Fisher Scientific Technology To Produce Polynucleotides For Drug Develo Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, and Thermo Fisher Scientific have entered into an agreement under which Dalton will use a proprietary Thermo Fisher manufacturing process to...
LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase II Clinical Program LifeCycle Pharma A/S announced recently positive results from the company's Phase II clinical program with LCP-AtorFen, a fixed-dose combination product of atorvastatin and fenofibrate for the treatment of mixed dyslipidemia.LCP...
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share - Strong European and Rest of the World Sales - Proprietary Product Sales Increase, Portfolio Expanded - Company Provides Updated Adjusted Calendar 2008 EPS Guidance of $2.75 - $3.05 MONTVALE, N.J., May 8 /PRNewswire-FirstCall/ -- Barr ...
Verticals onDemand Signs 15th Life Sciences Customer, Marking the Dawn of an Industry-Wide Conversion from Cli - In the last nine months, fifteen life sciences companies have signed with Verticals onDemand, the pharmaceutical industry's only provider of Software-as-a-Service (SaaS) CRM solutions.Verticals onDemand's latest customer, UK-based...
The Maybach Journal: IDM Pharma Reports First Quarter Financial Results (M2 PressWIRE Via Acquire Media NewsEdge) RDATE:08052008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world.Investors wanting to know the truth about investing and how to consistently...
Cytogen Reports First Quarter 2008 Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Cytogen Corporation (NASDAQ: CYTO - News) today reported its financial results for the first quarter of 2008.Cytogen reported a net loss of $5.9 million, or $0.16 per diluted share for the first quarter...
Par Pharmaceutical Reports First Quarter 2008 Results WOODCLIFF LAKE, N.J., May 8 /PRNewswire-FirstCall/ -- Par Pharmaceutical (News) Companies, Inc.today reported results for the first quarter ended March 29, 2008.
Par reported total revenues of $154.9 million and net income of $2.6...
Par Pharmaceutical Reports First Quarter 2008 Results Reports First Quarter Adjusted EPS of $0.17 per Diluted Share Provides Full-year 2008 EPS Guidance and Projects its Pipeline Opportunities WOODCLIFF LAKE, N.J., May 8 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.(NYSE...
Amneal Pharmaceuticals Receives US FDA Approval For Three Generic Prescription Drugs; Two Using New FDA Electr Amneal Pharmaceuticals is pleased to announce that it received US FDA approval to manufacture Primidone Tablets (50/250mg), Cyclobenzaprine Tablets (10mg) and Demeclocycline Tablets (150/300mg) within the last several weeks.Two of...
S&P: Royalty Pharma's Proposed $300M Unsecured Term Loan Rated 'BB+' -Standard & Poor's Ratings Services today assigned its 'BB+' rating to Royalty Pharma Finance Trust's proposed $300 million senior unsecured term loan due 2015.Proceeds will be used to fund the company's future acquisitions.
